ArticleBiomarker research2025

Chemotherapy in synergy with innate immune agonists enhances T cell priming for checkpoint inhibitor treatment in pancreatic cancer.

Nan Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.